X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2747) 2747
life sciences & biomedicine (2614) 2614
humans (1731) 1731
animals (1582) 1582
glucosides - therapeutic use (1558) 1558
male (1443) 1443
glucosides - pharmacology (1247) 1247
pharmacology & pharmacy (1112) 1112
female (825) 825
diabetes mellitus, type 2 - drug therapy (824) 824
hypoglycemic agents - therapeutic use (644) 644
mice (637) 637
rats (627) 627
benzhydryl compounds - therapeutic use (590) 590
middle aged (494) 494
diabetes (487) 487
type 2 diabetes (461) 461
chemistry, medicinal (428) 428
glucosides - chemistry (417) 417
glucose (411) 411
sodium-glucose transporter 2 - antagonists & inhibitors (405) 405
analysis (401) 401
glucosides - administration & dosage (396) 396
endocrinology & metabolism (378) 378
rats, sprague-dawley (366) 366
glucosides - adverse effects (348) 348
treatment outcome (342) 342
adult (332) 332
dose-response relationship, drug (330) 330
care and treatment (328) 328
aged (318) 318
chemistry (310) 310
plant extracts - pharmacology (299) 299
biochemistry & molecular biology (289) 289
disease models, animal (289) 289
research (289) 289
phytotherapy (281) 281
physical sciences (279) 279
plant sciences (272) 272
diabetes mellitus (271) 271
health aspects (251) 251
rodents (250) 250
apoptosis (249) 249
hypoglycemic agents - adverse effects (244) 244
inflammation (238) 238
dextrose (237) 237
glucosides - isolation & purification (234) 234
blood glucose - metabolism (231) 231
glucosides (227) 227
diabetes mellitus, type 2 - blood (226) 226
integrative & complementary medicine (226) 226
dapagliflozin (223) 223
cell biology (217) 217
plant extracts - therapeutic use (215) 215
benzhydryl compounds - adverse effects (214) 214
blood glucose - drug effects (210) 210
research article (210) 210
proteins (206) 206
oxidative stress (203) 203
pharmacology/toxicology (201) 201
plant extracts - chemistry (201) 201
apoptosis - drug effects (199) 199
hypoglycemic agents - pharmacology (198) 198
drug therapy, combination (192) 192
double-blind method (189) 189
antioxidants (187) 187
diabetes mellitus, type 2 - complications (186) 186
signal transduction - drug effects (183) 183
mice, inbred c57bl (182) 182
phenols - pharmacology (181) 181
internal medicine (176) 176
risk factors (176) 176
hypoglycemic agents - administration & dosage (172) 172
sodium (172) 172
benzhydryl compounds - pharmacology (171) 171
studies (171) 171
medicine, research & experimental (169) 169
research & experimental medicine (169) 169
clinical trials (168) 168
thiophenes - therapeutic use (168) 168
glucosides - pharmacokinetics (165) 165
rats, wistar (160) 160
physiological aspects (158) 158
drug therapy (155) 155
diabetes mellitus, type 2 - metabolism (154) 154
usage (152) 152
cells, cultured (151) 151
medicine (150) 150
sodium-glucose transporter 2 - metabolism (150) 150
cell line, tumor (149) 149
immunology (148) 148
general & internal medicine (147) 147
blood pressure (146) 146
body weight (146) 146
oxidative stress - drug effects (146) 146
time factors (144) 144
medicine, general & internal (143) 143
biomedicine (141) 141
cardiovascular system & cardiology (141) 141
benzhydryl compounds - administration & dosage (139) 139
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3228) 3228
Japanese (82) 82
Chinese (60) 60
German (39) 39
Spanish (20) 20
French (13) 13
Czech (8) 8
Italian (6) 6
Russian (5) 5
Portuguese (3) 3
Danish (2) 2
Polish (2) 2
Dutch (1) 1
Lithuanian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecules (Basel, Switzerland), ISSN 1420-3049, 01/2011, Volume 16, Issue 2, pp. 1021 - 1043
.... Recently, much attention has been paid to therapeutic strategies aimed at inhibiting neurotoxic microglial activation... 
Neuroprotection | Neuroinflammation | Natural products | Neurodegeneration | Microglia | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Encephalitis - prevention & control | Neuroprotective Agents - therapeutic use | Plant Extracts - chemistry | Stilbenes - therapeutic use | Biological Products - pharmacology | Fatty Alcohols - therapeutic use | Ginsenosides - pharmacology | Stilbenes - pharmacology | Benzyl Alcohols - therapeutic use | Biphenyl Compounds - therapeutic use | Ginsenosides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Fatty Alcohols - pharmacology | Microglia - physiology | Neuroprotective Agents - pharmacology | Biphenyl Compounds - pharmacology | Encephalitis - drug therapy | Catechols - therapeutic use | Nerve Degeneration - prevention & control | Benzyl Alcohols - pharmacology | Resveratrol | Catechols - pharmacology | Catechin - therapeutic use | Glucosides - therapeutic use | Molecular Structure | Catechin - pharmacology | Biological Products - therapeutic use | Glucosides - pharmacology | Curcumin - therapeutic use | Microglia - drug effects | Curcumin - pharmacology | Phenyl Ethers - pharmacology | Nerve Degeneration - pathology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Phenyl Ethers - therapeutic use | Catechin - analogs & derivatives | Index Medicus | neurodegeneration | natural products | neuroinflammation | microglia | neuroprotection
Journal Article
Toxicology and applied pharmacology, ISSN 0041-008X, 10/2017, Volume 333, pp. 43 - 50
Dipeptidyl peptidase-4 inhibitor (vildagliptin) has been shown to exert beneficial effects on insulin sensitivity and neuroprotection in obese-insulin... 
Obese-insulin resistance | Vildagliptin | Cognitive function | Mitochondrial function | Dapagliflozin | Synaptic plasticity | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Memory - drug effects | Neuroprotective Agents - therapeutic use | Reactive Oxygen Species - metabolism | Insulin - physiology | Nitriles - pharmacology | Obesity - drug therapy | Rats, Wistar | Apoptosis - drug effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Cognition Disorders - metabolism | Male | Membrane Potential, Mitochondrial - drug effects | Brain - physiology | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Brain - metabolism | Neuroprotective Agents - pharmacology | Long-Term Potentiation - drug effects | Diet, High-Fat | Malondialdehyde - blood | Adamantane - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Glucosides - therapeutic use | Benzhydryl Compounds - therapeutic use | Adamantane - analogs & derivatives | Malondialdehyde - metabolism | Adamantane - pharmacology | Cognition Disorders - physiopathology | Glucosides - pharmacology | Anti-Inflammatory Agents - pharmacology | Insulin Resistance | Obesity - physiopathology | Mitochondria - metabolism | Mitochondria - drug effects | Cognition Disorders - drug therapy | Maze Learning - drug effects | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Obesity - metabolism | Brain - drug effects | Animals | Benzhydryl Compounds - pharmacology | Oxidative Stress - drug effects | Mitochondria - physiology | Nitriles - therapeutic use | Obesity | Brain | Insulin resistance | Apoptosis | Analysis and chemistry | Low density lipoproteins | Cognition disorders | Glucose tolerance tests | Blood | High performance liquid chromatography | Neurophysiology | Index Medicus | INSULIN | APOPTOSIS | GLUCOSE | DRUGS | MITOCHONDRIA | RATS | SENSITIVITY | METABOLIC DISEASES | 60 APPLIED LIFE SCIENCES | BRAIN
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 05/2017, Volume 25, Issue 13, pp. 1549 - 1566
It is known that Cardiovascular (CV) disease is the leading cause of morbidity and mortality in individuals with type 2 diabetes. Over the last years, one of... 
Cardiovascular events | Pioglitazone | Sulfonylureas | Dipeptidyl peptidase-4 inhibitors | Glucagon-like peptide-1 receptor agonists | Metformin | Insulin | Sodium-glucose co-transporters-2 inhibitors | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Metformin - therapeutic use | Cardiovascular Diseases - drug therapy | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Pioglitazone - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Cardiovascular Diseases - complications | Glucagon-Like Peptides - pharmacology | Liraglutide - pharmacology | Glucosides - therapeutic use | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Insulin - pharmacology | Glucosides - pharmacology | Sodium-Glucose Transporter 2 - metabolism | Metformin - pharmacology | Pioglitazone - pharmacology | Hypoglycemic Agents - pharmacology | Liraglutide - therapeutic use | Benzhydryl Compounds - pharmacology | Glucagon-Like Peptides - therapeutic use | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Insulin - therapeutic use | Heart | Diabetes mellitus | Clinical trials | Diabetes | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Patients | Morbidity
Journal Article
Diabetes care, ISSN 1935-5548, 07/2014, Volume 37, Issue 7, pp. 1815 - 1823
Journal Article